Pages that link to "Q42491919"
Jump to navigation
Jump to search
The following pages link to Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence (Q42491919):
Displaying 50 items.
- Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 (Q24322566) (← links)
- Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells (Q24813407) (← links)
- Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients (Q28366039) (← links)
- Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells (Q30824578) (← links)
- Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland (Q33923773) (← links)
- Complex roles of tissue inhibitors of metalloproteinases in cancer (Q34596110) (← links)
- The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis (Q35012821) (← links)
- Surface association of secreted matrix metalloproteinases (Q35107600) (← links)
- Clinical implications of matrix metalloproteinases (Q35567569) (← links)
- Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis (Q35745865) (← links)
- TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis (Q35762042) (← links)
- Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. (Q35782300) (← links)
- Expression of tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma (Q35937773) (← links)
- Cysteine cathepsins in human cancer (Q35970409) (← links)
- Role of MMP-2 and MMP-9 in resistance to drug therapy in patients with resistant hypertension. (Q36024251) (← links)
- Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. (Q36292236) (← links)
- Caffeic Acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway (Q36504702) (← links)
- Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse (Q36611308) (← links)
- Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma (Q36617452) (← links)
- Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma (Q36671053) (← links)
- Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources (Q36789076) (← links)
- Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. (Q37130179) (← links)
- Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis (Q37169609) (← links)
- Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. (Q37486259) (← links)
- On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds (Q37836419) (← links)
- Inflammatory and microenvironmental factors involved in breast cancer progression (Q38162168) (← links)
- May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer? (Q38377310) (← links)
- Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells (Q39833926) (← links)
- Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. (Q40760681) (← links)
- Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. (Q40853467) (← links)
- Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line (Q40984834) (← links)
- High affinity binding of latent matrix metalloproteinase-9 to the alpha2(IV) chain of collagen IV. (Q41039346) (← links)
- How tumors become angiogenic (Q41100541) (← links)
- What we need to know about cancer genes (Q41694622) (← links)
- Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma (Q42279639) (← links)
- Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix. (Q42439078) (← links)
- Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy (Q43540159) (← links)
- MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival (Q44039747) (← links)
- Galectin-3 and L1 retrotransposons in human breast carcinomas (Q47718753) (← links)
- MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. (Q48166289) (← links)
- Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma. (Q51706058) (← links)
- High levels of TIMP-2 correlate with adverse prognosis in breast cancer. (Q52141709) (← links)
- Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer. (Q53445835) (← links)
- Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. (Q54939543) (← links)
- Similarities of in situ mRNA Expression between Gelatinase A (MMP‐2) and Type I Procollagen in Human Gastrointestinal Carcinoma: Comparison with Granulation Tissue Reaction (Q54966324) (← links)
- Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts. (Q64887058) (← links)
- Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas (Q71974606) (← links)
- The extracellular matrix produced by bovine corneal endothelial cells contains progelatinase A (Q72629873) (← links)
- Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma (Q73040964) (← links)
- In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis (Q73167028) (← links)